Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam versus topiramate adjunctive therapy in refractory partial onset seizures
2014-004402-15Phase 4
- Sponsor
- UCB
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in epilepsy comparing Levetiracetam adjunctive therapy with Topiramate adjunctive therapy (2 arms). Primary endpoint: Retention rate at Week 52.
02
Drugs
levetiracetamtopiramate
03
Conditions
epilepsy
Beyond the preview
Go deeper on 2014-004402-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004402-15.